Drug Profile
Research programme: anticancer therapeutic vaccine - Vedantra Precision Immunity
Alternative Names: ALK-ICMVs; E6-ICMVs; E7-ICMVsLatest Information Update: 18 Sep 2023
Price :
$50
*
At a glance
- Originator Vedantra Precision Immunity
- Class Antineoplastics; Immunotherapies; Vaccines
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; Human papillomavirus E6 protein inhibitors; Human papillomavirus E7 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Sep 2023 Discontinued - Preclinical for Cancer in USA (Parenteral)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
- 01 Sep 2016 Preclinical trials in Cancer in USA (Parenteral) before September 2016